by Tanya Thomas on  June 28, 2010 at 10:56 AM Diabetes News
 Fatality Risk Increases Sixfold in Diabetics With Minor Kidney Damage
Acoording to research results arrives at by the University of Pittsburgh Graduate School of Public Health, people with type 1 diabetes who have early and asymptomatic kidney damage (which is usually indicated by small amounts of protein in the urine), are six times more likely to die compared to the general population.

Their study also found that when kidneys remained normal over time, people with type 1 diabetes had no greater risk of death than their healthy counterparts.

Empowering Better Health

The findings were based on data from 658 men and women enrolled in the Pittsburgh Epidemiology of Diabetes Complications Study, a long-term prospective examination of childhood onset type 1 diabetes that began in 1986.

Researchers tested participants for levels of albumin, a protein that indicates early kidney damage when elevated in the urine and results in a condition called microalbuminuria.

After 20 years of follow-up, 152 participants (23 percent) with microalbuminuria had died - a rate 6.2 times higher than age- and sex-matched people in the general population.

When researchers excluded from the analysis participants who developed kidney damage after initial protein testing, they found that mortality rates for those with normal kidneys were no different than in the general population.

"Early stages of kidney disease in type 1 diabetes may be very important because they can lead to a sizeable increase in the risk of death," said Aaron M. Secrest, lead author of the study and a doctoral student at the University of Pittsburgh Graduate School of Public Health.

"The hopeful news is that this risk virtually disappears when kidneys remain healthy, which should encourage physicians to closely monitor kidney health in people with type 1 diabetes," Secrest added.

The study is being presented at the 70th Scientific Sessions of the American Diabetes Association.

Source: ANI

Most Popular on Medindia